A new pyridazinone exhibits potent cytotoxicity on human cancer cells via apoptosis and poly-ubiquitinated protein accumulation

被引:0
作者
Denisse A. Gutierrez
Rebecca E. DeJesus
Lisett Contreras
Isela A. Rodriguez-Palomares
Paulina J. Villanueva
Karol S. Balderrama
Lenore Monterroza
Manuel Larragoity
Armando Varela-Ramirez
Renato J. Aguilera
机构
[1] The University of Texas at El Paso,The Cytometry, Screening, and Imaging Core Facility, Border Biomedical Research Center, Department of Biological Sciences
来源
Cell Biology and Toxicology | 2019年 / 35卷
关键词
Anti-cancer; Apoptosis; Proteasome inhibition; Pyridazinone; ROS;
D O I
暂无
中图分类号
学科分类号
摘要
In the last 15 years, pyridazinone derivatives have acquired extensive attention due to their widespread biological activities and pharmacological applications. Pyridazinones are well known for their anti-microbial, anti-viral, anti-inflammatory, anti-cancer, and cardiovascular activities, among others. In this study, we evaluated the anti-cancer activity of a new pyridazinone derivative and propose it as a potential anti-neoplastic agent in acute promyelocytic leukemia cells. Pyr-1 cytotoxicity was assessed on several human cancer and two non-cancerous cell lines by the DNS assay. Pyr-1 demonstrated potent cytotoxicity against 22 human cancer cell lines, exhibiting the most favorable selective cytotoxicity on leukemia (CEM and HL-60), breast (MDA-MB-231 and MDA-MB-468), and lung (A-549) cancer cell lines, when compared with non-cancerous breast epithelial MCF-10A cells. Analyses of apoptosis/necrosis pathways, reactive oxygen species (ROS) production, mitochondria health, caspase-3 activation, and cell cycle profile were performed via flow cytometry. Both hmox-1 RNA and protein expression levels were evaluated by quantitative real-time PCR and Western blotting assays, respectively. Pyr-1 induced apoptosis in acute promyelocytic leukemia cells as confirmed by phosphatidylserine externalization, mitochondrial depolarization, caspase-3 activation, DNA fragmentation, and disrupted cell cycle progression. Additionally, it was determined that Pyr-1 generates oxidative and proteotoxic stress by provoking the accumulation of ROS, resulting in the overexpression of the stress-related hmox-1 mRNA transcripts and protein and a marked increase in poly-ubiquitinated proteins. Our data demonstrate that Pyr-1 induces cell death via the intrinsic apoptosis pathway by accumulating ROS and by impairing proteasome activity.
引用
收藏
页码:503 / 519
页数:16
相关论文
共 338 条
  • [1] Akhtar W(2016)The therapeutic journey of pyridazinone Eur J Med Chem 123 256-281
  • [2] Shaquiquzzaman M(2012)Combinatorial drug therapy for cancer in the post-genomic era Nat Biotechnol 30 679-692
  • [3] Akhter M(2002)The proteasome: a novel target for cancer chemotherapy Leukemia. 16 433-443
  • [4] Verma G(2015)A mini review on biological activities of pyridazinone derivatives as antiulcer, antisecretory, antihistamine and particularly against histamine H3R Mini-Rev Med Chem 14 1093-1103
  • [5] Khan MF(2006)Manipulating the apoptotic pathway: potential therapeutics for cancer patients Br J Clin Pharmacol 76 381-395
  • [6] Alam MM(2014)Induction of tumor cell apoptosis by a proteasome deubiquitinase inhibitor is associated with oxidative stress Antioxid Redox Signal 21 2271-2285
  • [7] Al-Lazikani B(2017)Enhanced degradation of misfolded proteins promotes tumorigenesis Cell Rep 18 3143-3154
  • [8] Banerji U(2018)Induction of apoptosis via proteasome inhibition in leukemia/lymphoma cells by two potent piperidones Cell Oncol 41 623-636
  • [9] Workman P(2015)New platelet aggregation inhibitors based on pyridazinone moiety Eur J Med Chem 94 113-122
  • [10] Almond JB(2011)Inhibition of proteasome deubiquitinating activity as a new cancer therapy Nat Med 17 1636-1640